Mar 22, 2026 | Abbott's $21B Exact Sciences Deal Closes; Wegovy HD Approved, Orforglipron Delayed

from The Pharma Closeout | Daily Pharmaceutical & Biotech News in 15 minus · host BZ Group

Abbott finalizes its ~$21B Exact Sciences acquisitionMonday, reshaping cancer diagnostics. Novo's Wegovy HD wins FDA approval as Lilly's orforglipron PDUFA slips to April 10. Plus: GSK's Lynavoy, Pfizer's TALAPRO-3 data, and Genentech's emugrobart setback. Full week-in-review.pharma, pharmaceutical, FDA, clinical trials, biotech, drugapprovals, healthcare, pharma podcast, The Pharma Closeout, Abbott, Exact Sciences, Cologuard, Oncotype DX, Novo Nordisk, Wegovy HD, semaglutide,orforglipron, Eli Lilly, GSK, Lynavoy, linerixibat, PBC, Pfizer, talazoparib, TALAPRO-3, prostate cancer, camrelizumab, rivoceranib, HCC, Rhythm Pharmaceuticals, Imcivree, Novartis, PI3K, Genentech, emugrobart, RocketPharmaceuticals, Kresladi, Lantheus, AAD 2026, M&A, obesity, GLP-1, diagnostics, Lilly

Episode metadata supplied by the publisher feed · Published Mar 23, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Mar 22, 2026 | Abbott's $21B Exact Sciences Deal Closes; Wegovy HD Approved, Orforglipron Delayed

0:00 11:14

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Pharma Closeout | Daily Pharmaceutical & Biotech News in 15 minus?

This episode is 11 minutes long.

When was this The Pharma Closeout | Daily Pharmaceutical & Biotech News in 15 minus episode published?

This episode was published on March 23, 2026.

Can I download this The Pharma Closeout | Daily Pharmaceutical & Biotech News in 15 minus episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!